Macrogenics (MGNX) Asset Utilization Ratio (2013 - 2026)
Macrogenics (MGNX) reported Asset Utilization Ratio of 0.66 for Q1 2026, down 3.78% year-over-year from 0.69 in Q1 2025, and up 16.78% quarter-over-quarter from 0.57 in Q4 2025.
Macrogenics (MGNX) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Macrogenics (MGNX) has 14 years of Asset Utilization Ratio data on file, last reported at 0.66 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.66, down 3.78% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.66 (down 3.78% YoY), and the FY2025 annual result was 0.58, up 7.68% from the prior year.
- Asset Utilization Ratio grew to 0.66 in Q1 2026 per MGNX's latest filing, from 0.57 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.79 in Q2 2025 and troughed at 0.15 in Q2 2024.
- A 5-year average of 0.47 and a median of 0.53 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio sank 71.18% in 2023, then soared 431.01% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.64 in 2022, then slumped by 71.18% to 0.18 in 2023, then soared by 236.87% to 0.62 in 2024, then fell by 8.6% to 0.57 in 2025, then gained by 16.78% to 0.66 in 2026.
- Business Quant data shows MGNX's Asset Utilization Ratio at 0.66 in Q1 2026, 0.57 in Q4 2025, and 0.57 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.66 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.57 |
| Jun 30, 2025 | 0.79 |
| Mar 31, 2025 | 0.69 |
| Dec 31, 2024 | 0.62 |
| Sep 30, 2024 | 0.57 |
| Jun 30, 2024 | 0.15 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.38 |
| Jun 30, 2023 | 0.47 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.64 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.27 |
| Mar 31, 2022 | 0.24 |
| Dec 31, 2021 | 0.21 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.20 |